OA13191A - Semi-solid systems containing azetidine derivatives. - Google Patents

Semi-solid systems containing azetidine derivatives. Download PDF

Info

Publication number
OA13191A
OA13191A OA1200600018A OA1200600018A OA13191A OA 13191 A OA13191 A OA 13191A OA 1200600018 A OA1200600018 A OA 1200600018A OA 1200600018 A OA1200600018 A OA 1200600018A OA 13191 A OA13191 A OA 13191A
Authority
OA
OAPI
Prior art keywords
composition
azetidine
derivative
active ingredient
pharmaceutical composition
Prior art date
Application number
OA1200600018A
Other languages
English (en)
Inventor
Maria-Teresa Peracchia
Sophie Cote
Valerie Bobineau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of OA13191A publication Critical patent/OA13191A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA1200600018A 2003-07-18 2004-07-08 Semi-solid systems containing azetidine derivatives. OA13191A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291796A EP1498122A1 (en) 2003-07-18 2003-07-18 Semi-solid systems containing azetidine derivatives

Publications (1)

Publication Number Publication Date
OA13191A true OA13191A (en) 2006-12-13

Family

ID=33462259

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200600018A OA13191A (en) 2003-07-18 2004-07-08 Semi-solid systems containing azetidine derivatives.

Country Status (30)

Country Link
US (2) US20050026898A1 (es)
EP (2) EP1498122A1 (es)
JP (1) JP2009513560A (es)
KR (1) KR20060040691A (es)
CN (1) CN1822831A (es)
AR (1) AR045997A1 (es)
AU (1) AU2004262498B2 (es)
BR (1) BRPI0412737A (es)
CA (1) CA2532669A1 (es)
CR (1) CR8179A (es)
EC (1) ECSP066292A (es)
GT (1) GT200400135A (es)
HR (1) HRP20060022A2 (es)
IL (1) IL173111A0 (es)
MA (1) MA27922A1 (es)
MX (1) MXPA06000483A (es)
MY (1) MY142077A (es)
NO (1) NO20060509L (es)
OA (1) OA13191A (es)
PA (1) PA8606701A1 (es)
PE (1) PE20050287A1 (es)
RS (1) RS20060016A (es)
RU (1) RU2343915C2 (es)
SG (1) SG144141A1 (es)
TN (1) TNSN06013A1 (es)
TW (1) TW200522945A (es)
UA (1) UA80633C2 (es)
UY (1) UY28421A1 (es)
WO (1) WO2005013973A1 (es)
ZA (1) ZA200600490B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007123366A (ru) * 2004-11-24 2008-12-27 Мерк Энд Ко. Жидкие и полутвердые фармацевтические препаративные формы для перорального введения замещенного амида
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
EP2637655B1 (en) * 2010-11-08 2019-01-09 Cadila Pharmaceuticals Ltd. Pharmaceutical composition of taxoids
EP3086777A1 (en) * 2013-12-23 2016-11-02 Johnson & Johnson Consumer Inc. Racecadotril compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0825849A1 (en) * 1995-05-19 1998-03-04 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs
EP1015046A2 (en) * 1998-07-14 2000-07-05 Em Industries, Inc. Microdisperse drug delivery systems
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine
EP1498123A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulsifying systems containing azetidine derivatives

Also Published As

Publication number Publication date
ZA200600490B (en) 2007-05-30
MXPA06000483A (es) 2006-04-05
AR045997A1 (es) 2005-11-23
AU2004262498B2 (en) 2009-01-22
TW200522945A (en) 2005-07-16
RS20060016A (en) 2008-06-05
AU2004262498A2 (en) 2005-02-17
AU2004262498A1 (en) 2005-02-17
US20080293686A1 (en) 2008-11-27
NO20060509L (no) 2006-01-31
TNSN06013A1 (en) 2007-10-03
PA8606701A1 (es) 2005-02-04
UY28421A1 (es) 2005-02-28
CA2532669A1 (en) 2005-02-17
BRPI0412737A (pt) 2006-09-26
RU2343915C2 (ru) 2009-01-20
JP2009513560A (ja) 2009-04-02
HRP20060022A2 (en) 2006-02-28
CR8179A (es) 2006-09-22
SG144141A1 (en) 2008-07-29
RU2006105011A (ru) 2006-06-10
UA80633C2 (en) 2007-10-10
CN1822831A (zh) 2006-08-23
MY142077A (en) 2010-08-30
US20050026898A1 (en) 2005-02-03
KR20060040691A (ko) 2006-05-10
MA27922A1 (fr) 2006-06-01
GT200400135A (es) 2005-08-25
WO2005013973A1 (en) 2005-02-17
EP1648442A1 (en) 2006-04-26
PE20050287A1 (es) 2005-06-13
IL173111A0 (en) 2006-06-11
EP1498122A1 (en) 2005-01-19
ECSP066292A (es) 2006-10-25

Similar Documents

Publication Publication Date Title
US20060166959A1 (en) Pharmaceutical compositions based on azetidine derivatives
HRP20060021A2 (en) Emulsifying systems containing azetidine derivatives
AU2002364866B2 (en) Pharmaceutical compositions based on azetidine derivatives
US20080293686A1 (en) Semi-solid systems containing azetidine derivatives
EP1498143A1 (en) Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
JP5116306B2 (ja) タキソイドの経口投与用半固体製剤
CN111093637A (zh) 药物组合物